Nuclera has raised $75 million, led by Elevage Medical Technologies, to commercialize its eProtein Discovery system. The ...

TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...

Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...

Johnson & Johnson has announced positive Phase II/III trial results for nipocalimab in generalized myasthenia gravis (gMG). The drug showed significant IgG reduction and sustained disease control.

The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...

UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...

Philadelphia, USA-based biopharma company Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners, with participation from ...

Amgen has reported positive Phase III results for Uplinza (inebilizumab-cdon) in treating generalized myasthenia gravis (gMG) ...

Commit Biologics has named Mikkel Wandahl Pedersen as CSO. Pedersen, with over 20 years in immuno-oncology, previously led ...

PharmaMar and Jazz Pharma positive top-line results from the Phase III clinical trial evaluating Zepzelca (lurbinectedin) in ...

Polish clinical-stage biotech Molecure has signed an exclusive licensing agreement with Ocean Biomedical based in Providence, ...

US clinical-stage genetic meds company MeiraGTx Holdings has released positive top-line data from its clinical bridging study ...